Literature DB >> 18183388

Aspergillus niger metabolism of citrus furanocoumarin inhibitors of human cytochrome P450 3A4.

Kyung Myung1, John A Manthey, Jan A Narciso.   

Abstract

Fungi metabolize polycyclic aromatic hydrocarbons by a number of detoxification processes, including the formation of sulfated and glycosidated conjugates. A class of aromatic compounds in grapefruit is the furanocoumarins (FCs), and their metabolism in humans is centrally involved in the "grapefruit/drug interactions." Thus far, the metabolism by fungi of the major FCs in grapefruit, including 6', 7'-epoxybergamottin (EB), 6', 7'-dihydroxybergamottin (DHB), and bergamottin (BM), has received little attention. In this study, Aspergillus niger was observed to convert EB into DHB and a novel water-soluble metabolite (WSM). Bergaptol (BT) and BM were also metabolized by A. niger to the WSM, which was identified as BT-5-sulfate using mass spectrometry, UV spectroscopy, chemical hydrolysis, and (1)H and (13)C nuclear magnetic resonance spectroscopy. Similarly, the fungus had a capability of metabolizing xanthotoxol (XT), a structural isomer of BT, to a sulfated analog of BT-5-sulfate, presumably XT-8-sulfate. A possible enzyme-catalyzed pathway for the grapefruit FC metabolism involving the cleavage of the geranyl group and the addition of a sulfate group is proposed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18183388     DOI: 10.1007/s00253-007-1314-0

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  2 in total

1.  Accelerated Development and Toxin Tolerance of the Navel Orangeworm Amyelois transitella (Lepidoptera: Pyralidae) in the Presence of Aspergillus flavus.

Authors:  Daniel S Bush; Joel P Siegel; May R Berenbaum
Journal:  J Chem Ecol       Date:  2018-10-28       Impact factor: 2.626

2.  Fumonisin and ochratoxin production in industrial Aspergillus niger strains.

Authors:  Jens C Frisvad; Thomas O Larsen; Ulf Thrane; Martin Meijer; Janos Varga; Robert A Samson; Kristian F Nielsen
Journal:  PLoS One       Date:  2011-08-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.